Williams-Sonoma, Uber And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Lisa Levin
Insiders at Williams-Sonoma, Uber Technologies, Vertex Pharmaceuticals, and Seagate Technology have recently sold shares of their companies. Williams-Sonoma's CEO sold shares after reporting better-than-expected earnings, while Uber's CEO sold shares following a revenue miss. Vertex Pharmaceuticals' EVP and CMO sold shares after a gene therapy received conditional marketing authorization in the UK. Seagate Technology's EVP & Chief Commercial Officer sold shares after reporting a significant revenue decline.
November 17, 2023 | 1:26 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vertex Pharmaceuticals' EVP and CMO sold shares valued at $2.15 million after a gene therapy received conditional marketing authorization in the UK.
The insider sale at Vertex Pharmaceuticals comes after a positive development for the company. The sale might be routine and not necessarily indicate a lack of confidence, leading to a neutral impact.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 60
NEUTRAL IMPACT
Williams-Sonoma's CEO sold shares valued at $2.82 million after the company reported strong earnings.
The sale by Williams-Sonoma's CEO could be interpreted as a lack of confidence or as a routine profit-taking after strong earnings. The impact is neutral as the earnings were positive, which might balance out concerns from the sale.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Seagate Technology's EVP & Chief Commercial Officer sold 5,000 shares at $75 each after the company reported a significant drop in revenues.
The sale by Seagate Technology's executive following a revenue decline could be perceived negatively by the market, suggesting a potential short-term negative impact on the stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 70
NEGATIVE IMPACT
Uber's CEO and another executive sold shares totaling approximately $5.28 million following a revenue miss in the third quarter.
The sale by Uber's CEO and another executive following a revenue miss could be seen as a negative signal, potentially leading to a short-term negative impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80